Physician profile
Robert Amajoyi
NPI 1417247800
$56,093.48
in general payments reported to CMS, 2019-2025
16 companies · $42K in 2025
The $42K reported for 2025 was more than what 98% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,363 · 2020: $954 · 2022: $413 · 2023: $308 · 2024: $6,346 · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Education: $17K · Food and Beverage: $3,669 · Travel and Lodging: $1,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,937.38 |
| Education | $17,040.00 |
| Food and Beverage | $3,668.97 |
| Travel and Lodging | $1,717.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evologics LLC | $25,937.38 | 2024-2025 | |
| Baxter Healthcare | $17,766.78 | 2024-2025 | Tisseel, Seprafilm, Floseal |
| Intuitive Surgical, INC. | $5,669.57 | 2019-2025 | |
| Medtronic, INC. | $1,944.80 | 2022-2025 | Signia, Interstim, Ligasure |
| Thd America, INC. | $1,697.60 | 2025 | |
| Medtronic USA, INC. | $1,445.35 | 2019-2020 | |
| Davol INC. | $439.98 | 2019-2025 | Surgiphor, Arista Ah Flexitip |
| Smith+Nephew, INC. | $341.20 | 2024-2025 | Stravix |
| Aroa Biosurgery Incorporated | $179.09 | 2025 | |
| W. L. Gore & Associates, INC. | $140.84 | 2022 | |
| Janssen Biotech, INC. | $136.89 | 2025 | Tremfya |
| Covidien LP | $130.69 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $128.50 | 2025 | |
| Dysis Medical, INC. | $101.65 | 2022 | |
| Ethicon US, LLC | $19.57 | 2024 | Echelon Flex |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $13.59 | 2025 | New Image |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Amajoyi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.